Synthesis, characterization and biological investigation of platinum(ii) complexes with asparagusic acid derivatives as ligands.


Journal

Dalton transactions (Cambridge, England : 2003)
ISSN: 1477-9234
Titre abrégé: Dalton Trans
Pays: England
ID NLM: 101176026

Informations de publication

Date de publication:
15 Jan 2019
Historique:
pubmed: 20 12 2018
medline: 4 4 2019
entrez: 20 12 2018
Statut: ppublish

Résumé

After more than 50 years of platinum-based anticancer research only three compounds are in clinical use worldwide. The use of the well-known lead compound of this class of anticancer agents, cisplatin, is limited by its side effects and varying resistance mechanisms. Therefore, we report on platinum(ii) compounds with asparagusic acid derivatives as ligands which show interesting anticancer results on cisplatin resistant cell lines.

Identifiants

pubmed: 30565617
doi: 10.1039/c8dt02553c
doi:

Substances chimiques

Antineoplastic Agents 0
Ligands 0
Organoplatinum Compounds 0
Thiophenes 0
1,2-dithiolane-4-carboxylic acid 2224-02-4
Cisplatin Q20Q21Q62J

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

936-944

Auteurs

Jana Hildebrandt (J)

Institut für Anorganische und Analytische Chemie Friedrich-Schiller-Universität Jena, Humboldstraße 8, 07743 Jena, Germany. wolfgang.weigand@uni-jena.de.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH